{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:56:01Z","timestamp":1761101761578},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,8,15]],"date-time":"2006-08-15T00:00:00Z","timestamp":1155600000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1038\/sj.bjc.6603306","type":"journal-article","created":{"date-parts":[[2006,8,15]],"date-time":"2006-08-15T11:16:12Z","timestamp":1155640572000},"page":"757-762","source":"Crossref","is-referenced-by-count":11,"title":["Optimal selection for BRCA1 and BRCA2 mutation testing using a combination of \u2018easy to apply\u2019 probability models"],"prefix":"10.1038","volume":"95","author":[{"given":"D","family":"Bodmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M J L","family":"Ligtenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A H","family":"van der Hout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Gloudemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Ansink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J C","family":"Oosterwijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Hoogerbrugge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,8,15]]},"reference":[{"key":"BF6603306_CR1","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PDP, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrj\u00e4koski K, Kallioniemi O-P, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72: 1117\u20131130","journal-title":"Am J Hum Genet"},{"key":"BF6603306_CR2","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1136\/jmg.2004.028829","volume":"42","author":"CJ van Asperen","year":"2005","unstructured":"van Asperen CJ, Brohet RM, Meijers-Heijboer EJ, Hoogerbrugge N, Verhoef S, Vasen HFA, Ausems MGEM, Menko FH, Gomez Garcia EB, Klijn JGM, Hogervorst FBL, van Houwelingen JC, Van\u2019t Veer LJ, Rookus MA, van Leeuwen FE, on behalf of the Netherlands Collaborative Group on Hereditary Breast Cancer (HEBON) (2005) Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet 42: 711\u2013719","journal-title":"J Med Genet"},{"key":"BF6603306_CR3","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1093\/annonc\/mdh474","volume":"15","author":"L Bermejo","year":"2004","unstructured":"Bermejo L, Hemminki K (2004) Risk of cancer at sites other than the breast in Swedisch families eligible for BRCA1 and BRCA2 mutation testing. Ann Oncol 15: 1834\u20131841","journal-title":"Ann Oncol"},{"key":"BF6603306_CR4","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1200\/JCO.2002.05.121","volume":"20","author":"DA Berry","year":"2002","unstructured":"Berry DA, Iversen Jr ES, Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN, Lerman C, Watson P, Lynch HT, Hilsenbeck SG, Rubinstein WS, Hughes KS, Parmigiani G (2002) BRCAPRO validation, sensitivity of genetic testing of BRCA1\/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20: 2701\u20132712","journal-title":"J Clin Oncol"},{"key":"BF6603306_CR5","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1001\/jama.293.8.964","volume":"293","author":"EB Claus","year":"2005","unstructured":"Claus EB, Petruzella S, Matloff E, Carter D (2005) Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ. JAMA 293: 964\u2013969","journal-title":"JAMA"},{"key":"BF6603306_CR6","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1093\/jnci\/90.23.1824","volume":"90","author":"EB Claus","year":"1998","unstructured":"Claus EB, Schildkraut J, Iversen Jr ES, Berry D, Parmigiani G (1998) Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history. J Natl Cancer Inst 90: 1824\u20131829","journal-title":"J Natl Cancer Inst"},{"key":"BF6603306_CR7","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1136\/jmg.40.7.503","volume":"40","author":"M De la Hoya","year":"2003","unstructured":"De la Hoya M, Diez O, Perez-Segura P, Godino J, Fernandez JM, Sanz J, Alonso C, Baiget M, Diaz-Rubio E, Caldes T (2003) Pre-test prediction models of BRCA1 or BRCA2 mutation in breast\/ovarian families attending familial cancer clinics. J Med Genet 40: 503\u2013510","journal-title":"J Med Genet"},{"key":"BF6603306_CR8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1200\/JCO.2003.07.007","volume":"21","author":"SM Domchek","year":"2003","unstructured":"Domchek SM, Eisen A, Calzone K, Stopfer J, Blackwood A, Weber BL (2003) Application of breast cancer risk prediction models in clinical practice. J Clin Oncol 21: 593\u2013601","journal-title":"J Clin Oncol"},{"key":"BF6603306_CR9","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1136\/jmg.2003.017996","volume":"41","author":"DGR Evans","year":"2004","unstructured":"Evans DGR, Eccles DM, Rahman N, Young K, Bulman M, Amir E, Shenton A, Howell A, Lalloo F (2004) A new scoring system for the chances of identifying a BRCA1\/2 mutation outperforms existing models including BRCAPRO. J Med Genet 41: 474\u2013480","journal-title":"J Med Genet"},{"key":"BF6603306_CR10","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1136\/jmg.2005.031989","volume":"42","author":"DGR Evans","year":"2005","unstructured":"Evans DGR, Lalloo F, Wallace A, Rahman N (2005) Update on the Manchester scoring system for BRCA1 and BRCA2 testing. J Med Genet 42: e39","journal-title":"J Med Genet"},{"key":"BF6603306_CR11","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1200\/JCO.2002.20.6.1480","volume":"20","author":"TS Frank","year":"2002","unstructured":"Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, Gumpper KL, Scholl T, Tavtigian SV, Pruss DR, Critchfield GC (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20: 1480\u20131490","journal-title":"J Clin Oncol"},{"key":"BF6603306_CR12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1034\/j.1399-0004.2000.580408.x","volume":"58","author":"CA Gilpin","year":"2000","unstructured":"Gilpin CA, Carson N, Hunter AG (2000) A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics centre. Clin Genet 58: 299\u2013308","journal-title":"Clin Genet"},{"key":"BF6603306_CR13","first-page":"1449","volume":"63","author":"FB Hogervorst","year":"2003","unstructured":"Hogervorst FB, Nederlof PM, Gille JJ, McElgunn CJ, Grippeling M, Pruntel R, Regnerus R, van Welsem T, van Spaendonk R, Menko FH, Kluijt I, Dommering C, Verhoef S, Schouten JP, van\u2019t Veer LJ, Pals G (2003) Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res 63: 1449\u20131453","journal-title":"Cancer Res"},{"key":"BF6603306_CR14","first-page":"A410","volume":"65","author":"AH Hout van der","year":"1999","unstructured":"Hout van der AH, Mulder IM, Wu Y, van der Vlies P, Huisman M, Oosterwijk JC, Buys CHCM, Hofstra RMW (1999) A DGGE system for comprehensive mutation screening of the complete coding regions of BRCA1 and BRCA2 outside exons 11. Am J Hum Genet 65: A410","journal-title":"Am J Hum Genet"},{"key":"BF6603306_CR15","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/sj.bjc.6690235","volume":"79","author":"MJ Ligtenberg","year":"1999","unstructured":"Ligtenberg MJ, Hogervorst FB, Willems HW, Arts PJ, Brink G, Hageman S, Bosgoed EA, Van der Looij E, Rookus MA, Devilee P, Vos EM, Wigbout G, Struycken PM, Menko FH, Rutgers EJ, Hoefsloot EH, Mariman EC, Brunner HG, Van\u2019t Veer LJ (1999) Characteristics of small breast and\/or ovarian cancer families with germline mutations in BRCA1 and BRCA2. Br J Cancer 79: 1475\u20131478","journal-title":"Br J Cancer"},{"key":"BF6603306_CR16","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/jmg.2003.013623","volume":"41","author":"F Marroni","year":"2004","unstructured":"Marroni F, Aretini P, D\u2019Andrea E, Caligo MA, Cortesi L, Viel A, Ricevuto E, Montagna M, Cipollini G, Ferrari S, Santarosa M, Bisegna R, Bailey-Wilson JE, Bevilacqua G, Parmigiani G, Presciuttini S (2004) Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations. J Med Genet 41: 278\u2013285","journal-title":"J Med Genet"},{"key":"BF6603306_CR17","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/jama.279.12.915","volume":"279","author":"B Newman","year":"1998","unstructured":"Newman B, Mu H, Butler LM, Millikan RC, Moorman PG, King MC (1998) Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA 279: 915\u2013921","journal-title":"JAMA"},{"key":"BF6603306_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1086\/301670","volume":"62","author":"G Parmigiani","year":"1998","unstructured":"Parmigiani G, Berry D, Aguilar O (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62: 145\u2013158","journal-title":"Am J Hum Genet"},{"key":"BF6603306_CR19","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/jnci\/91.11.943","volume":"91","author":"J Peto","year":"1999","unstructured":"Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Stratton MR (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91: 943\u2013949","journal-title":"J Natl Cancer Inst"},{"key":"BF6603306_CR20","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/ijc.11271","volume":"106","author":"S Sanjose","year":"2003","unstructured":"Sanjose S, Leone M, Berez V, Izquierdo A, Font R, Brunet JM, Louat T, Vilardell L, Borras J, Viladiu P, Bosch FX, Lenoir GM, Sinilnikova OM (2003) Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study. Int J Cancer 106: 588\u2013593","journal-title":"Int J Cancer"},{"key":"BF6603306_CR21","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1093\/nar\/gnf056","volume":"30","author":"JP Schouten","year":"2002","unstructured":"Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30: e57","journal-title":"Nucleic Acids Res"},{"key":"BF6603306_CR22","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1093\/jnci\/92.18.1529","volume":"92","author":"K Syrjakoski","year":"2000","unstructured":"Syrjakoski K, Vahteristo P, Eerola H, Tamminen A, Kivinummi K, Sarantaus L, Holli K, Blomqvist C, Kallioniemi OP, Kainu T, Nevanlinna H (2000) Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients. J Natl Cancer Inst 92: 1529\u20131531","journal-title":"J Natl Cancer Inst"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6603306.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6603306","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6603306.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:22:47Z","timestamp":1684412567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6603306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,15]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["BF6603306"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6603306","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,15]]}}}